Medical Sales Representative
Minimum Diploma in any science discipline or Graduate in any discipline preferably in Life Science and Pharmacology
Certified training for Medical Sales Representative (programme aligned to LFS/Q0401 released by Life Sciences Sector Skill Development Council)
Freshers may apply subject to the age restriction which is approximately 26 years. This may vary from company to company.
The tasks a Medical Sales Representative is expected to perform include:
Gathering information about the products and competitors before promoting his/her company?s product
Gathering, analysing and evaluating market data and recommending improvements/changes
Attending educational and organizational workshops relating to drug/chemical/clinical studies, reviewing publications and establishing networks in the industry
Selling products to potential and existing customers and providing after sales services
Contacting and persuading potential customers and maintaining and strengthening existing customer relationships
Planning and organizing medical conferences and promotional events
Knowledge of the different methods and techniques of collecting, interpreting and analysing market data
Well-versed with methods of entering and submitting data through IT applications
Knowledge and understanding of the scientific profiling of products to be sold its composition, benefits, methods of consumption and use, side-effects, etc.Understanding the importance of company protocols while organizing events
Knowledge of industry eco system, regulations and ethical practices (MCI code of conduct/UCP-MP guidelines/MRTP Act)Knowledge of the human anatomy
Detailed knowledge of physiology and its related medical terms
Knowledge of drug transport mechanism in the human body
Knowledge of therapeutic drug, its classes, pharmacovigilance and disease management
Detailed knowledge of the production of the product, its components and its subscription
Knowledge of pharmacology and pharmacovigilance process
Problem solving skills
Planning and organizing skills
Objection handling skills
Analytical and critical thinking ability
It is mostly a field job
Need not handle a team Involves extensive travelling
Part-time work is not available
Work from home option is not available
Working is 8 hours everyday for 6 days a week
The job involves working extended hours and occasional working on weekends/holidays
Is the job suitable for a candidate with special needs?Maybe
This job is not considered hazardous or dangerous Occupational hazard include fatigue, body ache, stress etc.
For freshers - INR 5,000 toINR 10,000 per month
For candidates with upto 2 yearsexperience - INR 8,000 to INR 20,000 per month
For candidates with over 2 yearsexperience INR15,000 to INR 50,000 or above per month
(These figures are indicative and subject to change)
Life Sciences Sector
India?s Pharmaceutical Industry
India's drugs and pharmaceuticals industry is expected to grow at a compound annual growth rate (CAGR) of 14 per cent to reach a turnover of`2.91 trillion (US$ 47.06 billion) by 2018.
The domestic drugs industry, which is valued at`1.6 trillion (US$ 25.87 billion) at present, according to Care Ratings, is also expected to grow in the local market with aggressive rural penetration by drug makers, increased government spending on health, and growing health awareness among people.
India exports pharmaceutical products to more than 200 countries. Pharmaceutical exports are expected to cross the`1 trillion (US$ 16.17 billion) mark this year. "The growth would be around 15 per cent and is driven by formulation exports," said Dr PV Appaji, Director-General, Pharmaceutical Export Promotion Council (Pharmexcil). During 2013-14, pharma exports stood at`90,000 crore (US$ 14.55 billion). Out of this, the share of formulations was 71 per cent.India currently exports drug intermediates, Active Pharmaceutical Ingredients (APIs), Finished Dosage Formulations (FDFs), bio-pharmaceuticals, and clinical services across the globe.
The domestic formulations market stood at an estimated INR 722 billion in FY14, registering a growth of 6 percent over FY13. The y-o-y growth rate has seen a decline over the last 2 years. The decline is attributed to the reduction in the number of patients with chronic diseases such as diabetes, the switch to generic drugs and fewer number of product approval. Sales of chronic therapy drugs grew faster than the sales of acute therapy drugs and the sales of anti-diabetic, cardiovascular (CVS) and neuro/CNS therapeutic drugs recorded the fastest growth. There are more than 500 manufacturers in the organized and unorganized segments. Top ten players account for around 40 percent of the total market share. Of the total number of pharmaceutical manufacturers, about 77 percent produce formulations while the remaining 23 percent manufacture bulk drugs. Indian companies are currently focusing on in-licensing their products and alliances/JVs due to a slowdown in product approvals. OTC segment is emerging as a source of high growth in the short to medium-term. Realization improvement is seen as another key focus area. Increasing number of medical representatives across segments coupled with improving quality of deliverables has led to an increase in sales numbers. Growth of chronic therapeutics is on a rise with changing demographics and lifestyle patterns. There are about 40.8 million patients diagnosed with diabetes in India and is expected to grow to 70 million by 2025. General economic slowdown is not likely to impact the chronic therapeutics segment as major proportion of patients in this segment belongs to upper strata of society.
Pharmaceutical/Bio pharmaceutical (including AYUSH and Neutraceuticals) companies (domestic formulations)Sales and marketing agencies
Across towns and cities in India
Will be updated